Center volume for fetal aortic valvuloplasty is not associated with technical success or complications but is linked to lower periprocedural death.

The Harmony transcatheter pulmonary valve (TPV) system [Image courtesy of Medtronic] Medtronic (NYSE:MDT) has issued a letter to affected customers recommending the removal of certain lots of its ...

Scientists have uncovered evidence that serotonin, the chemical best known for regulating mood, may also speed the ...

Cardiac Dimensions announced today that it published three manuscripts providing new evidence supporting its Carillon mitral ...

Nyra Medical, Inc., a clinical-stage medical technology company developing a novel transcatheter solution for functional mitral regurgitation (FMR), today announced enrollment of the first patient in ...

Soft robotic heart simulator from UNSW Sydney replicates mitral valve disease and heart failure to test cardiac devices ...

New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and Advances Understanding of the Trilogy ® System in ...

We aimed to synthesize existing evidence on predictive machine learning (ML) models for valvular heart disease (VHD) and examine how these models have been applied across clinical tasks, data ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Evolving International Clinical Guidelines and ConsensusMitral regurgitation (MR) is one of the most prevalent valvular heart diseases worldwide. FMR, which commonly occurs in patients with heart fail ...